DBS: Deep brain stimulation; GPi: Globus pallidus internal; STN: Subthalamic nucleus. Although in some late-onset Parkinson's disease (PD) patients, L-Dopa-induced dyskinesia (LIDs) may be quite ...
SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today presented data detailing the baseline characteristics of patients with Parkinson's disease (PD) in the ...
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
If you have advanced Parkinson’s disease (PD), you may hear about a treatment option called vyalev (foscarbidopa/foslevodopa). It was approved by the FDA in 2024 ...
Explore Duopa, an advanced Parkinson's disease treatment that uses carbidopa-levodopa gel infusion for steady dopamine levels, reducing motor fluctuations effectively.
Tardive dyskinesia causes involuntary movements in some people taking antipsychotic medications. Here’s what you need to know about this movement disorder. Antipsychotic medications are a mainstay of ...
Nonpharmacological Therapies for Dyskinesia: The Success of Deep Brain Stimulation In recent decades, the widespread utilization of deep brain stimulation (DBS) worldwide, although so far limited to ...